Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) versus FitLife Brands (NASDAQ:FTLF) Financial Survey

FitLife Brands (NASDAQ:FTLF) and Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Institutional & Insider Ownership

2.3% of FitLife Brands shares are held by institutional investors. 61.3% of FitLife Brands shares are held by company insiders. Comparatively, 0.9% of Rock Creek Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares FitLife Brands and Rock Creek Pharmaceuticals”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$62.76 million	2.37	$5.30 million	$1.69	19.13
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

FitLife Brands has higher revenue and earnings than Rock Creek Pharmaceuticals.

Profitability

This table compares FitLife Brands and Rock Creek Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Rock Creek Pharmaceuticals	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for FitLife Brands and Rock Creek Pharmaceuticals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0	0	1	1	3.50
Rock Creek Pharmaceuticals	0	0	0	0	0.00

FitLife Brands presently has a consensus target price of $40.00, indicating a potential upside of 23.70%. Given FitLife Brands’ stronger consensus rating and higher probable upside, research analysts clearly believe FitLife Brands is more favorable than Rock Creek Pharmaceuticals.

Summary

FitLife Brands beats Rock Creek Pharmaceuticals on 10 of the 10 factors compared between the two stocks.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.